Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04305600 · ClinicalTrials.gov registry record

Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction in ICU Survivors, 2nd Study

A clinical trial of Critical Illness and Intensive Care Unit Delirium, sponsored by Vanderbilt University Medical Center.

Active
Registry status
567
Enrollment target
2
Study locations

NCT04305600: Active study of Critical Illness and Intensive Care Unit Delirium, sponsored by Vanderbilt University Medical Center.

NCT04305600 is a study of Critical Illness and Intensive Care Unit Delirium that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 567 participants, below the 3,132-participant average among 91 other Critical Illness trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04305600, a study of Critical Illness and Intensive Care Unit Delirium, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
567 participants
Enrollment target
2
Study locations

Study Summary

This BRAIN-ICU-2 study \[Bringing to light the Risk factors And Incidence of Neuropsychological dysfunction (dementia) in ICU Survivors, 2nd Study\] is in direct response to PAR-17-038 and will determine ICU patients' main paths to decline, maintenance, or recovery of brain function. We will answer gaps in knowledge about long-term outcome of post-ICU brain disease by following the remaining ICU survivors from the original BRAIN-ICU-1 study with complete cognitive testing for the first time ever to 12 years (AIM 1). We will consent and enroll 567 new ICU patients at Vanderbilt and Rush Universities (i.e., BRAIN-ICU-2 cohort) and determine how detailed neuroimaging and cerebrospinal fluid samples can help reveal locations and mechanisms of injury beyond what we learned from the clinical information collected in our original study (AIM 2). Importantly, we are mirroring the existing world-renowned Rush Alzheimer's Disease Research Center brain bank program so that all patients enrolled in Aims 1 and 2 will able to donate their brains to science for the first-ever in-depth pathological study of those who do and do not get post-ICU dementia to define this disease formally (AIM 3)

Study Locations (2)

Illinois

  • Rush University Medical Center - Chicago

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 567 participants
Start Date 2020-10-01
Est. Completion 2029-01-31

What the registry record for NCT04305600 still lists

NCT04305600 is an observational study that tracks outcomes without assigning an intervention. The registered 567 participants enrollment target is mid-sized for trials with a published cap, below the 3,132-participant average among 91 other Critical Illness trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 0 interventions.

NCT04305600 reports a single indexed study location in Illinois, Tennessee.

Frequently Asked Questions

What is clinical trial NCT04305600 about?

NCT04305600 is a clinical study titled "Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction in ICU Survivors, 2nd Study". This BRAIN-ICU-2 study \[Bringing to light the Risk factors And Incidence of Neuropsychological dysfunction (dementia) in ICU Survivors, 2nd Study\] is in direct response to PAR-17-038 and will determine ICU patients' main paths to decline, maintenance, or recovery of brain function. We will answer ...

What is the current status of trial NCT04305600?

This trial is currently active not recruiting. The enrollment target is 567 participants. The study started on 2020-10-01. Estimated completion is 2029-01-31.

What conditions does trial NCT04305600 study?

This clinical trial studies the following conditions: Critical Illness, Intensive Care Unit Delirium.

Who is sponsoring clinical trial NCT04305600?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04305600 being conducted?

This trial has 2 study locations across Illinois, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04305600's enrollment target sits among peer trials

567 26th of 91 higher than 66 of 91 other Critical Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05472441 · 568 participants · NA

    Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)

  • NCT05000645 · 570 participants · NA

    Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women

  • NCT06239844 · 570 participants · NA

    Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English

  • NCT06701903 · 570 participants · Phase 2

    Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04305600, the US trial registry maintained by the National Library of Medicine. NCT04305600 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.